In summary, PD-1 upregulation occurs in all molecular B-ALL subgroups tested, although the percentage of PD-1+ leukemic cells varied from 2 to 100% per sample. This evidence concerns the gene PDCD1 and precursor B-cell acute lymphoblastic leukemia.